Venous thromboembolism: “…an ounce of prevention is worth a pound of cure”

• References

• 1 Mozaffarian D, Benjamin EJ, Go AS. et al. Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation 2015; 131: e29-e322.
• 2 Huang W, Goldberg RJ, Anderson FA. et al. Secular trends in occurrence of acute venous thromboembolism: the Worcester VTE study (1985–2009). Am J Med 2014; 127: 829-839 e825.
• 3 Riva N, Donadini M, Ageno W. Epidemiology and pathophysiology of venous thromboembolism: similarities with atherthrombosis and the role of inflammation. Thromb Haemost 2015; 113: 1176-1183.
• 4 Righini M, Le Gal G, Bounameaux H. Venous thromboembolism diagnosis: unresolved issues. Thromb Haemost 2015; 113: 1184-1192.
• 5 Hillis C, Crowther M. Acute phase treatment of VTE: anticoagulation, including non-vitamin K antagonist oral anticoagulants. Thromb Haemost 2015; 113: 1193-1201.
• 6 Konstantinides S, Waerntges S. Acute phase treatment of venous thromboembolism: advanced therapy. Thromb Haemost 2015; 113: 1202-1209.
• 7 Prandoni P. Optimal duration of anticoagulation: provoked versus unprovoked VTE and role of adjunctive thrombophilia and imaging tests. Thromb Haemost 2015; 113: 1210-1215.
• 8 Granziera S, Cohen A. VTE. primary prention, including hospitalized medical and orthopedic surgical patients. Thromb Haemost 2015; 113: 1216-1223.